ScholarIQanswers from OpenAlex
Inflammation biomarkers and pathways
TopicLeading institutions, researchers & key papers
Inflammation biomarkers and pathways is a topic indexed in ScholarIQ from OpenAlex.
What is known about Inflammation biomarkers and pathways?
ScholarIQrecord summary
This cluster of papers explores the role of triggering receptor expressed on myeloid cells-1 (TREM-1) and endocan in inflammatory responses, sepsis, and various inflammatory diseases. It investigates their impact on immune cells such as macrophages and neutrophils, as well as their potential as diagnostic markers for conditions like pneumonia and septic shock.
How many works does Inflammation biomarkers and pathways have?
ScholarIQindexed works
Inflammation biomarkers and pathways has 73 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
What is the OpenAlex record for Inflammation biomarkers and pathways?
ScholarIQopenalex
The OpenAlex for Inflammation biomarkers and pathways is on the source record.
What are the most-cited papers on Inflammation biomarkers and pathways?
ScholarIQmost cited works
TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis
Gernot Kleinberger, Yoshinori Yamanishi, Marc Suárez‐Calvet, Eva Czirr, Ebba Lohmann, Elise Cuyvers, Hanne Struyfs, Nadine Pettkus, Andrea Wenninger-Weinzierl, Fargol Mazaheri, Sabina Tahirović, Alberto Lleó, Daniel Alcolea, Juan Fortea, Michael Willem, Sven Lammich, José Luís Molinuevo, Raquel Sánchez‐Valle, Anna Antonell, Alfredo Ramı́rez, Michael T. Heneka, Kristel Sleegers, Julie van der Zee, Jean‐Jacques Martin, Sebastiaan Engelborghs, Aslı Demirtaş-Tatlıdede, Henrik Zetterberg, Christine Van Broeckhoven, Hakan Gürvıt, Tony Wyss‐Coray, John Hardy, Marco Colonna, Christian Haass
The <i>MS4A</i> gene cluster is a key modulator of soluble TREM2 and Alzheimer’s disease risk
Yuetiva Deming, Fabia Filipello, Francesca Cignarella, Claudia Cantoni, Simon Hsu, Robert Mikesell, Zeran Li, Jorge L. Del‐Aguila, Umber Dube, Fabiana Farias, Joseph Bradley, John Budde, Laura Ibáñez, María Victoria Fernández, Kaj Blennow, Henrik Zetterberg, Amanda Heslegrave, Per Johansson, Johan Svensson, Bengt Nellgård, Alberto Lleó, Daniel Alcolea, Jordi Clarimón, Lorena Rami, José Luís Molinuevo, Marc Suárez‐Calvet, Estrella Morenas‐Rodríguez, Gernot Kleinberger, Michael Ewers, Oscar Harari, Christian Haass, Tom J. Brett, Bruno A. Benítez, Celeste M. Karch, Laura Piccio, Carlos Cruchaga
TREM-1 Exacerbates Neuroinflammatory Injury via NLRP3 Inflammasome-Mediated Pyroptosis in Experimental Subarachnoid Hemorrhage
Pengfei Xu, Ye Hong, Yi Xie, Kang Yuan, Juanji Li, Rui Sun, Xiaohao Zhang, Xiaolei Shi, Rongrong Li, Jiaonan Wu, Xinfeng Liu, Wei Hu, Wen Sun
TREM-1 Expression in Tumor-associated Macrophages and Clinical Outcome in Lung Cancer
Chao‐Chi Ho, Wei‐Yu Liao, Cheng-Yi Wang, Yin-Hsiu Lu, Hsin‐Yi Huang, Hsuan‐Yu Chen, Wing‐Kai Chan, Huei‐Wen Chen, Pan‐Chyr Yang
Endocan Expression Correlated with Poor Survival in Human Hepatocellular Carcinoma
Gengwen Huang, Yiming Tao, Xiang Ding
Where is Inflammation biomarkers and pathways research published, and who funds it?
ScholarIQvenues & funding sources
TOP JOURNALS
TOP FUNDERS
National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock
How much of the research on Inflammation biomarkers and pathways is open access?
ScholarIQopen access share
25%OPEN ACCESS